应对药品短缺保障供应的国际实践及对我国的启示

发布时间：2018-01-24 19:17

本文关键词： 药品短缺药品供应应对国际经验　出处：《中国药房》2017年18期 　论文类型：期刊论文

【摘要】：目的:为我国从根本上解决药品短缺问题提出政策建议。方法:分析我国药品短缺的原因,检索分析2010年以来中国、美国、加拿大、欧洲国家相关文献和各国家卫生、药监等相关部门官网发布的有关短缺药品供应保障的政策和措施。结果与结论:我国药品短缺为监管性、政策性、不正当竞争性短缺;国内外都面临着不同程度的药品短缺问题,需方和供方的原因都有;应以患者为中心,健全应对药品短缺相关法规体系,建立多方协调机制及短缺监测体系和信息沟通网络平台,留给药品生产配送企业合理的利润空间,打击囤积原料药的行为。典型国家明确药品供应链中所有利益相关者的职责、建立相对完善的应对药品短缺的政策体系和协调机制的经验值得我国借鉴。
[Abstract]:Objective: to put forward some policy suggestions for solving the problem of drug shortage in China. Methods: to analyze the causes of drug shortage in China, and to search and analyze China, the United States and Canada since 2010. The policies and measures on the supply and security of shortage drugs published on the official websites of European countries and other relevant departments of health and drug supervision. Results and conclusion: the shortage of drugs in China is regulatory and policy-oriented. Unfair competitive shortage; At home and abroad are faced with different degrees of drug shortage, the reasons for both the demand and the supply side; We should take the patient as the center, perfect the regulation system to deal with the drug shortage, establish the multi-party coordination mechanism, the shortage monitoring system and the information communication network platform, and leave a reasonable profit space for the pharmaceutical production and distribution enterprises. In typical countries, the responsibilities of all stakeholders in the pharmaceutical supply chain are clearly defined, and the experience of establishing a relatively perfect policy system and coordination mechanism to deal with drug shortages is worthy of our country's reference.
【作者单位】：中国医学科学院/北京协和医学院公共卫生学院;
【基金】：中央级公益性科研院所基本项目国家卫生计生委药政司委托研究课题(No.药政[2016]9号)
【分类号】：R95
【正文快照】： 药品短缺不仅发生在低收入国家,很多发展中国短缺的“氛围”,借机涨价,从中渔利[14]。家,甚至越来越多的发达国家也面临该类问题。美国早2应对药品短缺的国际经验在2001年就出现了处方药品短缺[1],2011年,一些基本由于各国的卫生体制等政策环境不同,短缺的原因药物(主要是化学

【参考文献】